Meet Jen. She’s a 42-year-old wife and mother of two living in Washington. She loves exploring nature, traveling, and trying new art mediums. Jen was diagnosed with HER2+ early breast cancer. Given the size and extent of the cancer, she was eligible for IV PERJETA (pertuzumab) + Herceptin (trastuzumab) + chemo. After finishing the chemo portion of her treatment, her doctor switched her to PHESGO.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.